Literature DB >> 12460720

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

R H Müller1, M Radtke, S A Wissing.   

Abstract

Solid lipid nanoparticles (SLN) were developed at the beginning of the 1990 s as an alternative carrier system to emulsions, liposomes and polymeric nanoparticles. The paper reviews advantages-also potential limitations-of SLN for the use in topical cosmetic and pharmaceutical formulations. Features discussed include stabilisation of incorporated compounds, controlled release, occlusivity, film formation on skin including in vivo effects on the skin. As a novel type of lipid nanoparticles with solid matrix, the nanostructured lipid carriers (NLC) are presented, the structural specialties described and improvements discussed, for example, increase in loading capacity, physical and chemical long-term stability, triggered release and potentially supersaturated topical formulations. For both SLN and NLC, the technologies to produce the final topical formulation are described, especially the production of highly concentrated lipid nanoparticle dispersions >30-80% lipid content. Production issues also include clinical batch production, large scale production and regulatory aspects (e. g. status of excipients or proof of physical stability).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460720     DOI: 10.1016/s0169-409x(02)00118-7

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  207 in total

1.  Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.

Authors:  Akhayacatra Chinsriwongkul; Ponwanit Chareanputtakhun; Tanasait Ngawhirunpat; Theerasak Rojanarata; Warisada Sila-on; Uracha Ruktanonchai; Praneet Opanasopit
Journal:  AAPS PharmSciTech       Date:  2011-12-14       Impact factor: 3.246

2.  Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy.

Authors:  Sylvia A Wissing; Rainer H Müller; Lars Manthei; Christian Mayer
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

3.  Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Karthik Yadav Janga; Prakash Bhagav; Soumyajit Majumdar
Journal:  Int J Pharm       Date:  2017-06-17       Impact factor: 5.875

4.  Novel beads made of alpha-cyclodextrin and oil for topical delivery of a lipophilic drug.

Authors:  Laury Trichard; M Begoña Delgado-Charro; Richard H Guy; Elias Fattal; Amélie Bochot
Journal:  Pharm Res       Date:  2007-08-02       Impact factor: 4.200

Review 5.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

6.  Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A.

Authors:  Pallavi V Pople; Kamalinder K Singh
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

7.  Nanoparticles: Emerging carriers for drug delivery.

Authors:  Sagar R Mudshinge; Amol B Deore; Sachin Patil; Chetan M Bhalgat
Journal:  Saudi Pharm J       Date:  2011-04-21       Impact factor: 4.330

Review 8.  Cure of tuberculosis using nanotechnology: An overview.

Authors:  Rout George Kerry; Sushanto Gouda; Bikram Sil; Gitishree Das; Han-Seung Shin; Gajanan Ghodake; Jayanta Kumar Patra
Journal:  J Microbiol       Date:  2018-05-02       Impact factor: 3.422

9.  Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery.

Authors:  Mangesh R Bhalekar; Varsha Pokharkar; Ashwini Madgulkar; Nilam Patil; Nilkanth Patil
Journal:  AAPS PharmSciTech       Date:  2009-03-18       Impact factor: 3.246

10.  Herbal ethosomal gel containing luliconazole for productive relevance in the field of biomedicine.

Authors:  Vivek Dave; Nishant Bhardwaj; Nikita Gupta; Kajal Tak
Journal:  3 Biotech       Date:  2020-02-06       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.